The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,108.00
Bid: 1,108.00
Ask: 1,110.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.181%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,108.00
SVS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

28 Apr 2020 15:53

RNS Number : 2105L
Savills PLC
28 April 2020
 

SAVILLS PLC (THE 'COMPANY')

NOTIFICATION OF INTERESTS OF DIRECTORS/ PERSONS DISCHARGING MANAGERIAL RESPONSIBILIES ('PDMRS')

 

Vesting and Grant of Share Awards

 

Awards made on 18 April 2017 over ordinary shares of the Company under the Company's Deferred Share Plans have now become unconditional in all respects following the end of their Deferred Period. In satisfaction of the Awards, the Trustee of The Savills plc 1992 Employee Benefit Trust ('Trustee') effected the transfer of shares, following the settlement of associated tax liabilities through the sale of shares which completed on 27 April 2020, to Directors and PDMRS of the Company as detailed in the table below.

 

The Company also announces that on 27 April 2020 the grant of the share based element of 2019 profit share awards was made under the Savills Deferred Share Bonus Plan to Directors and PDMRS of the Company as detailed in the table below.

 

Director / PDMR

Number of Shares Transferred to Director / PDMR by Trustee

Number of Shares sold by Trustee to settle associated tax liabilities

Director / PDMR Shareholding following this notification

Shareholding as a % of issued share capital

Number of Shares subject to the Savills Deferred Share Bonus Plan awarded to the Director / PDMR

Beneficial interest under the Deferred Share Plans following this notification

Mark Ridley (Director)

27,360

24,357

210,321

0.15%

85,446

171,611

Simon Shaw (Director)

26,715

23,783

182,579

0.13%

63,821

175,537

Simon Hope (PDMR)

3,693

3,271

190,789

0.13%

5,652

18,781

Chris Lee (PDMR)

7,122

6,343

112,138

0.08%

13,329

37,851

Christian Mancini (PDMR)

8,183

n/a

112,407

0.08%

7,974

26,789

Mitchell Rudin (PDMR)

n/a

n/a

34,158

0.02%

12,811

184,756

James Sparrow (PDMR)

n/a

n/a

58,798

0.04%

35,681

69,140

Mitchell Steir (PDMR)

5,187

5,644

52,500

0.04%

21,488

46,033

 

The share price on disposal of shares to settle associated tax liabilities was £8.823376 per share.

All the above awards have a Deferred Period of three years and are subject to rolled-up dividend shares whereby the number of shares awarded will be increased on the vesting date to reflect final and interim dividends declared during the Deferred Period.

The information set out below is provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation No 596/2014.

1.

Details of the person discharging managerial responsibilities/ person closely associated

 

(a)

Name

1. Mark Ridley

2. Simon Shaw

3. Simon Hope

4. Chris Lee

5. Christian Mancini

6. Mitchell Rudin

7. James Sparrow

8. Mitchell Steir

 

2.

Reason for the notification

 

(a)

Position/ status

1. Group Chief Executive/ Director

2. Group Chief Financial Officer/ Director

3. Global Head of Capital Markets/ PDMR

4. Group Legal Director and Company Secretary/ PDMR

5. Chief Executive Officer Asia Pacific (ex-Greater China) / PDMR

6. President, Savills US / PDMR

7. Chief Executive Officer UK & EMEA/ PDMR

8. Chairman and CEO - Savills North America/ PDMR

 

(b)

Initial notification/ Amendment

 

Initial notification

3.

Details of the issuer

 

(a)

Name

Savills plc

 

(b)

LEI

213800WXICGMBWHTA933

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

(a)

Description of the Financial Instrument

 

Awards over Savills plc Ordinary Shares of 2.5p each

(b)

Identification code of the Financial Instrument

 

GB00B135BJ46

(c)

Nature of the transaction

 

Vesting of awards under the Company's Deferred Share Plans and sale of shares to settle associated tax liabilities

(d)

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

Number of Shares Transferred at nil cost by Trustee to Director / PDMR

 

1. 27,360

2. 26,715

3. 3,693

4. 7,122

5. 8,183

6. n/a

7. n/a

8. 5,187

 

Number of Shares sold by Trustee to settle tax liabilities at £8.823376 per share

 

1. 24,357

2. 23,783

3. 3,271

4. 6,343

5. n/a

6. n/a

7. n/a

8. 5,644

 

(e)

Aggregated information

 

- Aggregated volume

- Price

 

N/A

 

 

(f)

Date of the transaction

 

27 April 2020

(g)

Place of the transaction

 

Outside a trading venue

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

(a)

Description of the Financial Instrument

 

Awards over Savills plc Ordinary Shares of 2.5p each

(b)

Identification code of the Financial Instrument

 

GB00B135BJ46

(c)

Nature of the transaction

 

Grant of awards over Ordinary Shares in accordance with the Company's Deferred Share Bonus Plan ('DSBP')

 

(d)

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

£nil per share

 

1. 85,446

2. 63,821

3. 5,652

4. 13,329

5. 7,974

6. 12,811

7. 35,681

8. 21,488

 

(e)

Aggregated information

 

- Aggregated volume

- Price

 

N/A

 

 

(f)

Date of the transaction

 

27 April 2020

(g)

Place of the transaction

 

Outside a trading venue

 

Name of contact and telephone number for queries:

Chris Lee

Group Legal Director & Company Secretary

020 3107 5444

 

28 April 2020

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHKZGZDDRGGGZM
Date   Source Headline
30th Mar 20237:47 amRNSAdditional Listing
16th Mar 20237:00 amRNSFinal Results
14th Mar 20235:07 pmRNSHolding(s) in Company
13th Mar 202311:06 amRNSDirector/PDMR Shareholding
1st Mar 202310:00 amRNSTotal Voting Rights
16th Feb 202311:17 amRNSBlock listing Interim Review
13th Feb 20234:32 pmRNSDirector/PDMR Shareholding
23rd Jan 202312:45 pmRNSBlock listing Interim Review
12th Jan 20234:10 pmRNSDirector/PDMR Shareholding
12th Jan 20237:00 amRNSYear End Trading Update
15th Dec 202211:59 amRNSNon-Executive Director Appointment
13th Dec 20221:20 pmRNSDirector/PDMR Shareholding
2nd Dec 202211:00 amRNSAdditional Listing
24th Nov 20223:25 pmRNSDirector/PDMR Shareholding
14th Nov 20229:29 amRNSDirector/PDMR Shareholding
11th Oct 20224:21 pmRNSDirector/PDMR Shareholding
10th Oct 20224:36 pmRNSDirector/PDMR Shareholding
30th Sep 202210:00 amRNSDirector/PDMR Shareholding
13th Sep 20225:24 pmRNSDirector/PDMR Shareholding
1st Sep 202210:07 amRNSTotal Voting Rights
31st Aug 202210:00 amRNSDirector/PDMR Shareholding
16th Aug 20223:33 pmRNSBlock listing Interim Review
16th Aug 202211:12 amRNSDirector/PDMR Shareholding
11th Aug 20224:12 pmRNSDirector/PDMR Shareholding
11th Aug 20227:00 amRNSHalf-year Report
12th Jul 20223:34 pmRNSDirector/PDMR Shareholding
1st Jul 20223:56 pmRNSDirector/PDMR Shareholding
1st Jul 202210:00 amRNSTotal Voting Rights
20th Jun 20224:33 pmRNSHolding(s) in Company
17th Jun 20227:29 amRNSHolding(s) in Company
15th Jun 202212:00 pmRNSHolding(s) in Company
10th Jun 20223:46 pmRNSHolding(s) in Company
1st Jun 20222:22 pmRNSHolding(s) in Company
1st Jun 202210:00 amRNSTotal Voting Rights
31st May 20222:53 pmRNSHolding(s) in Company
27th May 202210:00 amRNSHolding(s) in Company
26th May 20223:56 pmRNSDirector/PDMR Shareholding
17th May 20225:17 pmRNSHolding(s) in Company
17th May 20225:12 pmRNSHolding(s) in Company
11th May 20225:44 pmRNSDirector/PDMR Shareholding
11th May 20222:22 pmRNSResult of AGM
11th May 20229:56 amRNSAGM Statement
3rd May 20227:00 amRNSTotal Voting Rights
27th Apr 20224:13 pmRNSDirectors Remuneration Report - Clarification
21st Apr 20224:57 pmRNSDirector/PDMR Shareholding
21st Apr 20224:44 pmRNSHolding(s) in Company
12th Apr 20222:23 pmRNSDirector/PDMR Shareholding
4th Apr 20224:28 pmRNSAnnual Report and AGM Notice
1st Apr 202210:00 amRNSTotal Voting Rights
14th Mar 202210:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.